Xuechong Hong

Xuechong Hong

Auto-generated profile, based on publicly available information

Xuechong Hong

Department of Cardiac Surgery, Boston Children’s Hospital, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
KWKai Wang
Kai Wang
RLRuei-Zeng Lin
Ruei-Zeng Lin
XHXuechong Hong
Xuechong Hong
ANAlex H. Ng
Alex H. Ng
CLChin Nien Lee
Chin Nien Lee
JMJuan M. Melero-Martin
Juan M. Melero-Martin
Human induced pluripotent stem cell (h-iPSC)–derived endothelial cells (h-iECs) have become a valuable tool in regenerative medicine. However, current differentiation protocols remain inefficient and lack reliability. Here, we describe a method for rapid, consistent, and highly efficient generation of h-iECs. The protocol entails the delivery of modified mRNA encoding the transcription factor ETV2 at the intermediate mesodermal stage of differentiation. This approach reproducibly differentiated 13 diverse h-iPSC lines into h-iECs with exceedingly high efficiency. In contrast, standard differentiation methods that relied on endogenous ETV2 were inefficient and notably inconsistent. Our h-iECs were functionally competent in many respects, including the ability to form perfused vascular networks in vivo. Timely activation of ETV2 was critical, and bypassing the mesodermal stage produced putative h-iECs with reduced expansion potential and inability to form functional vessels. Our protocol has broad applications and could reliably provide an unlimited number of h-iECs for vascular therapies.

22 July 2022 in Science Advances
Verified
Journal Article
Open access
XWXi Wang
Xi Wang
KWKai Wang
Kai Wang
MYMing Yu
Ming Yu
DVDiana Velluto
Diana Velluto
XHXuechong Hong
Xuechong Hong
MMMinglin Ma
Minglin Ma
Islet transplantation has been established as a viable treatment modality for type 1 diabetes. However, the side effects of the systemic immunosuppression required for patients often outweigh its benefits. Here, we engineer programmed death ligand-1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein–modified mesenchymal stromal cells (MSCs) as accessory cells for islet cotransplantation. The engineered MSCs (eMSCs) improved the outcome of both syngeneic and allogeneic islet transplantation in diabetic mice and resulted in allograft survival for up to 100 days without any systemic immunosuppression. Immunophenotyping revealed reduced infiltration of CD4 + or CD8 + T effector cells and increased infiltration of T regulatory cells within the allografts cotransplanted with eMSCs compared to controls. The results suggest that the eMSCs can induce local immunomodulation and may be applicable in clinical islet transplantation to reduce or minimize the need of systemic immunosuppression and ameliorate its negative impact.

18 December 2019 in Blood Advances
Verified
Journal Article
Open access
PDF file
JNJoseph Neumeyer
Joseph Neumeyer
RLRuei-Zeng Lin
Ruei-Zeng Lin
KWKai Wang
Kai Wang
XHXuechong Hong
Xuechong Hong
THTien Hua
Tien Hua
JMJuan M. Melero-Martin
Juan M. Melero-Martin
Key Points: HA-specific iPSC-derived ECs overexpress full-length F8 after genetic engineering via a piggyBac transposon system. Bioengineered microvascular grafts deliver full-length FVIII into the bloodstream and restore hemostasis in hemophilic SCID mice.

17 January 2021 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
XHXuechong Hong
Xuechong Hong
NONicholas Oh
Nicholas Oh
KWKai Wang
Kai Wang
JNJoseph Neumeyer
Joseph Neumeyer
CLChin Nien Lee
Chin Nien Lee
JMJuan M. Melero-Martin
Juan M. Melero-Martin

9 July 2021 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
HKHwan D. Kim
Hwan D. Kim
XHXuechong Hong
Xuechong Hong
YAYoung‐Hyeon An
Young‐Hyeon An
MPMihn Jeong Park
Mihn Jeong Park
Do-Gyoon KimDo-Gyoon Kim
Do-Gyoon Kim
JMJuan M. Melero‐Martin
Juan M. Melero‐Martin
In article number 2100070, Juan M. Melero-Martin, Ruei-Zeng Lin, and co-workers present a biphasic scaffold that allows self-sustained endochondral ossification. Following seeding with human vascular and mesenchymal stem cells, this biomimetic material enables the rapid generation of osteovascular niches and ossification centers, leading to the formation of vascularized bone tissue in vivo.